Government of Dubai Report issue

Government Phase 1 Phase 3

Organization Overview

First Clinical Trial
2012
NCT04443387
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Consultant and Head of Physical Medicine and rehabilitation Department- Dubai hospital | Dubai Health Authority

Active Ingredients

Drugs in Phase 3 Trials (1)

frondanol (1 trial)

Drugs in Phase 1 Trials (2)

hyaluronic acid (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Trigger Finger Disorder (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4